Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study

BACKGROUND: Due to potentially immune-escaping virus variants and waning immunity, a third SARS-CoV-2 vaccination dose is increasingly recommended. However, data in patients with cancer are limited. PATIENTS AND METHODS: We measured anti-SARS-CoV-2 spike protein antibody levels after the third vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Mair, Maximilian J., Berger, Julia M., Mitterer, Manfred, Gansterer, Margaretha, Bathke, Arne C., Trutschnig, Wolfgang, Berghoff, Anna S., Perkmann, Thomas, Haslacher, Helmuth, Lamm, Wolfgang W., Raderer, Markus, Tobudic, Selma, Fuereder, Thorsten, Buratti, Thomas, Fong, Dominic, Preusser, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818387/
https://www.ncbi.nlm.nih.gov/pubmed/35248840
http://dx.doi.org/10.1016/j.ejca.2022.01.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818387/
https://www.ncbi.nlm.nih.gov/pubmed/35248840
http://dx.doi.org/10.1016/j.ejca.2022.01.019

Ejemplares similares